{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:40:46Z","timestamp":1791420046478,"version":"4.3.3"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,30]],"date-time":"2015-01-30T00:00:00Z","timestamp":1422576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"},{"start":{"date-parts":[[2015,1,30]],"date-time":"2015-01-30T00:00:00Z","timestamp":1422576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep08126","type":"journal-article","created":{"date-parts":[[2015,1,30]],"date-time":"2015-01-30T05:04:42Z","timestamp":1422594282000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":156,"title":["Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach"],"prefix":"10.1038","volume":"5","author":[{"given":"Dirk W.","family":"Lachenmeier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Rehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,30]]},"reference":[{"key":"BFsrep08126_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3109\/16066359909004376","volume":"7","author":"R Coomber","year":"1999","unstructured":"Coomber, R. Assessing the real dangers of illicit drugs - Risk analysis as the way forward? Addict. Res. 7, 85\u201390 (1999).","journal-title":"Addict. Res."},{"key":"BFsrep08126_CR2","first-page":"271","volume":"111","author":"B Fischer","year":"1997","unstructured":"Fischer, B., Kendall, P., Rehm, J. & Room, R. Charting WHO-goals for licit and illicit drugs for the year 2000: are we \u2018on track\u2019? Public Health 111, 271\u2013275 (1997).","journal-title":"Public Health"},{"key":"BFsrep08126_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000317249","volume":"16","author":"J van Amsterdam","year":"2010","unstructured":"van Amsterdam, J., Opperhuizen, A., Koeter, M. & van den Brink, W. Ranking the harm of alcohol, tobacco and illicit drugs for the individual and the population. Eur. Addict. Res. 16, 202\u2013207 (2010).","journal-title":"Eur. Addict. Res."},{"key":"BFsrep08126_CR4","unstructured":"UNODC. Towards the Creation of an Illicit Drug Index. World drug report 2005. Volume 1: Analysis [165\u2013174] (United Nations Office on Drugs and Crime, Vienna, Austria, 2005)."},{"key":"BFsrep08126_CR5","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/hup.1090","volume":"25","author":"LA King","year":"2010","unstructured":"King, L. A. & Corkery, J. M. An index of fatal toxicity for drugs of misuse. Hum. Psychopharmacol. 25, 162\u2013166 (2010).","journal-title":"Hum. Psychopharmacol."},{"key":"BFsrep08126_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3109\/00952999309001618","volume":"19","author":"RS Gable","year":"1993","unstructured":"Gable, R. S. Toward a comparative overview of dependence potential and acute toxicity of psychoactive substances used nonmedically. Am. J. Drug Alcohol Abuse 19, 263\u2013281 (1993).","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"BFsrep08126_CR7","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/j.1360-0443.2004.00744.x","volume":"99","author":"RS Gable","year":"2004","unstructured":"Gable, R. S. Comparison of acute lethal toxicity of commonly abused psychoactive substances. Addiction 99, 686\u2013696 (2004).","journal-title":"Addiction"},{"key":"BFsrep08126_CR8","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S0140-6736(07)60464-4","volume":"369","author":"D Nutt","year":"2007","unstructured":"Nutt, D., King, L. A., Saulsbury, W. & Blakemore, C. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet 369, 1047\u20131053 (2007).","journal-title":"Lancet"},{"key":"BFsrep08126_CR9","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/S0140-6736(10)61462-6","volume":"376","author":"DJ Nutt","year":"2010","unstructured":"Nutt, D. J., King, L. A. & Phillips, L. D. Drug harms in the UK: a multicriteria decision analysis. Lancet 376, 1558\u20131565 (2010).","journal-title":"Lancet"},{"key":"BFsrep08126_CR10","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1177\/0269881113477744","volume":"27","author":"CJ Morgan","year":"2013","unstructured":"Morgan, C. J., Noronha, L. A., Muetzelfeldt, M., Fielding, A. & Curran, H. V. Harms and benefits associated with psychoactive drugs: findings of an international survey of active drug users. J. Psychopharmacol. 27, 497\u2013506 (2013).","journal-title":"J. Psychopharmacol."},{"key":"BFsrep08126_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/0269881109106915","volume":"24","author":"CJ Morgan","year":"2010","unstructured":"Morgan, C. J., Muetzelfeldt, L., Muetzelfeldt, M., Nutt, D. J. & Curran, H. V. Harms associated with psychoactive substances: findings of the UK National Drug Survey. J. Psychopharmacol. 24, 147\u2013153 (2010).","journal-title":"J. Psychopharmacol."},{"key":"BFsrep08126_CR12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3109\/14659890903271624","volume":"15","author":"RL Carhart-Harris","year":"2010","unstructured":"Carhart-Harris, R. L. & Nutt, D. J. User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study. J. Substance Use 15, 283\u2013300 (2010).","journal-title":"J. Substance Use"},{"key":"BFsrep08126_CR13","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/j.1360-0443.2009.02830.x","volume":"105","author":"H Kalant","year":"2010","unstructured":"Kalant, H. Drug classification: science, politics, both or neither? Addiction 105, 1146\u20131149 (2010).","journal-title":"Addiction"},{"key":"BFsrep08126_CR14","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S0140-6736(11)60194-3","volume":"377","author":"LC Claridge","year":"2011","unstructured":"Claridge, L. C. Drugs and harm to society. Lancet 377, 552 (2011).","journal-title":"Lancet"},{"key":"BFsrep08126_CR15","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1111\/j.1360-0443.2011.03461.x","volume":"106","author":"JP Caulkins","year":"2011","unstructured":"Caulkins, J. P., Reuter, P. & Coulson, C. Basing drug scheduling decisions on scientific ranking of harmfulness: false promise from false premises. Addiction 106, 1886\u20131890 (2011).","journal-title":"Addiction"},{"key":"BFsrep08126_CR16","unstructured":"IPCS. IPCS Risk Assessment Terminology (World Health Organization, Geneva, 2004)."},{"key":"BFsrep08126_CR17","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/0272-0590(84)90107-6","volume":"4","author":"KS Crump","year":"1984","unstructured":"Crump, K. S. A new method for determining allowable daily intakes. Fundam. Appl. Toxicol. 4, 854\u2013871 (1984).","journal-title":"Fundam. Appl. Toxicol."},{"key":"BFsrep08126_CR18","unstructured":"U.S.EPA. The use of the benchmark dose approach in health risk assessment. EPA\/630\/R-94\/007 (Office of Research and Development. US Environmental Protection Agency, Washington, DC, 1995)."},{"key":"BFsrep08126_CR19","doi-asserted-by":"crossref","unstructured":"EFSA. Opinion of the Scientific Committee on a request from EFSA related to a harmonised approach for risk assessment of substances which are both genotoxic and carcinogenic. EFSA J. 282, 1\u201331 (2005).","DOI":"10.2903\/j.efsa.2005.282"},{"key":"BFsrep08126_CR20","doi-asserted-by":"publisher","first-page":"E995","DOI":"10.1002\/ijc.27553","volume":"131","author":"DW Lachenmeier","year":"2012","unstructured":"Lachenmeier, D. W., Przybylski, M. C. & Rehm, J. Comparative risk assessment of carcinogens in alcoholic beverages using the margin of exposure approach. Int. J. Cancer 131, E995\u2013E1003 (2012).","journal-title":"Int. J. Cancer"},{"key":"BFsrep08126_CR21","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/ije\/dyq150","volume":"40","author":"DW Lachenmeier","year":"2011","unstructured":"Lachenmeier, D. W., Kanteres, F. & Rehm, J. Epidemiology-based risk assessment using the benchmark dose\/margin of exposure approach: the example of ethanol and liver cirrhosis. Int. J. Epidemiol. 40, 210\u2013218 (2011).","journal-title":"Int. J. Epidemiol."},{"key":"BFsrep08126_CR22","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.yrtph.2011.10.017","volume":"62","author":"J Xie","year":"2012","unstructured":"Xie, J. et al. A probabilistic risk assessment approach used to prioritize chemical constituents in mainstream smoke of cigarettes sold in China. Regul. Toxicol. Pharmacol. 62, 355\u2013362 (2012).","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"BFsrep08126_CR23","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1016\/j.fct.2011.07.019","volume":"49","author":"FH Cunningham","year":"2011","unstructured":"Cunningham, F. H., Fiebelkorn, S., Johnson, M. & Meredith, C. A novel application of the Margin of Exposure approach: Segregation of tobacco smoke toxicants. Food Chem. Toxicol. 49, 2921\u20132933 (2011).","journal-title":"Food Chem. Toxicol."},{"key":"BFsrep08126_CR24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/02791072.1986.10472361","volume":"18","author":"AT Shulgin","year":"1986","unstructured":"Shulgin, A. T. The background and chemistry of MDMA. J. Psychoactive Drugs 18, 291\u2013304 (1986).","journal-title":"J. Psychoactive Drugs"},{"key":"BFsrep08126_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0273-2300(02)00026-0","volume":"37","author":"LS Gold","year":"2003","unstructured":"Gold, L. S., Gaylor, D. W. & Slone, T. H. Comparison of cancer risk estimates based on a variety of risk assessment methodologies. Regul. Toxicol. Pharmacol. 37, 45\u201353 (2003).","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"BFsrep08126_CR26","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.scitotenv.2012.06.069","volume":"432","author":"KV Thomas","year":"2012","unstructured":"Thomas, K. V. et al. Comparing illicit drug use in 19 European cities through sewage analysis. Sci. Total Environ. 432, 432\u2013439 (2012).","journal-title":"Sci. Total Environ."},{"key":"BFsrep08126_CR27","unstructured":"Erowid. Notes on heroin dosage and tolerance (http:\/\/www.erowid.org\/chemicals\/heroin\/heroin_dose1.shtml, (2001), Date of access: 2014\/04\/13)."},{"key":"BFsrep08126_CR28","unstructured":"UNODC. World Drug Report 2013 (United Nations Office on Drugs and Crime, Vienna, Austria, 2013)."},{"key":"BFsrep08126_CR29","unstructured":"Musshoff, F., Lachenmeier, D. W. & Madea, B. Cocain Und Cocainmetaboliten. Haaranalytik-Technik und Interpretation in Medizin und Recht [Madea B., & Musshoff F. (eds.)] [163\u2013178] (Deutscher \u00c4rzte-Verlag, Cologne, Germany, 2004)."},{"key":"BFsrep08126_CR30","unstructured":"Musshoff, F., Lachenmeier, D. W. & Madea, B. Cannabinoide. Haaranalytik-Technik und Interpretation in Medizin und Recht [Madea B., & Musshoff F. (eds.)] [179\u2013188] (Deutscher \u00c4rzte-Verlag, Cologne, Germany, 2004)."},{"key":"BFsrep08126_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00213-008-1260-2","volume":"201","author":"CC Hunault","year":"2008","unstructured":"Hunault, C. C. et al. Delta-9-tetrahydrocannabinol (THC) serum concentrations and pharmacological effects in males after smoking a combination of tobacco and cannabis containing up to 69\u2005mg THC. Psychopharmacol. (Berl.) 201, 171\u2013181 (2008).","journal-title":"Psychopharmacol. (Berl.)"},{"key":"BFsrep08126_CR32","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/ntr\/ntt219","volume":"16","author":"T Land","year":"2014","unstructured":"Land, T. et al. Recent increases in efficiency in cigarette nicotine delivery: Implications for tobacco control. Nicotine Tob. Res. 16, 753\u2013758 (2014).","journal-title":"Nicotine Tob. Res."},{"key":"BFsrep08126_CR33","unstructured":"OECD. OECD.Stat Extracts. Non-Medical Determinants of Health. MetaData. Tobacco consumption. http:\/\/stats.oecd.org\/index.aspx?queryid=30127, (2014), Date of access: 2014\/04\/13."},{"key":"BFsrep08126_CR34","unstructured":"WHO. Global Health Observatory Data Repository. Tobacco control. Monitor: Prevalence - adult age-standardized. Data by country (World Health Organization, Geneva, Switzerland. http:\/\/apps.who.int\/gho\/data\/node.main.1250?lang=en, (2014), Date of access: 2014-04-24)."},{"key":"BFsrep08126_CR35","first-page":"1","volume":"12","author":"SB Leavitt","year":"2003","unstructured":"Leavitt, S. B. Methadone dosing & safety in the treatment of opioid addiction. Addiction Treatment Forum 12, 1\u20138 (2003).","journal-title":"Addiction Treatment Forum"},{"key":"BFsrep08126_CR36","unstructured":"Musshoff, F., Lachenmeier, D. W. & Madea, B. Amphetamine. Haaranalytik-Technik und Interpretation in Medizin und Recht [Madea B., & Musshoff F. (eds.)] [189\u2013205] (Deutscher \u00c4rzte-Verlag, Cologne, Germany, 2004)."},{"key":"BFsrep08126_CR37","unstructured":"Erowid. Methamphetamine dosage (http:\/\/www.erowid.org\/chemicals\/meth\/meth_dose.shtml, (2003), Date of access: 2014\/04\/23)."},{"key":"BFsrep08126_CR38","unstructured":"NHTSA. Drugs and human performance fact sheets. Methylenedioxymethamphetamine (MDMA, Ecstasy) (http:\/\/www.nhtsa.gov\/people\/injury\/research\/job185drugs\/methylenedioxymethamphetamine.htm, (2014), Date of access: 2014\/04\/23)."},{"key":"BFsrep08126_CR39","unstructured":"NHTSA. Drugs and human performance fact sheets. Diazepam (http:\/\/www.nhtsa.gov\/people\/injury\/research\/job185drugs\/diazepam.htm, (2014), Date of access: 2014\/04\/23)."},{"key":"BFsrep08126_CR40","unstructured":"EMCDDA. Benzodiazepines. European Monitoring Centre for Drugs and Drug Addiction (http:\/\/www.emcdda.europa.eu\/publications\/drug-profiles\/benzodiazepine, (2013), Date of access: 2014\/04\/24)."},{"key":"BFsrep08126_CR41","unstructured":"WHO. Global status report on alcohol and health - 2014 ed. (World Health Organization, Geneva, Switzerland, 2014)."},{"key":"BFsrep08126_CR42","unstructured":"EMCDDA. Cocaine and crack. European Monitoring Centre for Drugs and Drug Addiction (http:\/\/www.emcdda.europa.eu\/publications\/drug-profiles\/cocaine, (2013), Date of access: 2014\/06\/12)."},{"key":"BFsrep08126_CR43","doi-asserted-by":"publisher","first-page":"143S","DOI":"10.1002\/j.1552-4604.1981.tb02589.x","volume":"21","author":"RT Jones","year":"1981","unstructured":"Jones, R. T., Benowitz, N. L. & Herning, R. I. Clinical relevance of cannabis tolerance and dependence. J. Clin. Pharmacol. 21, 143S\u2013152S (1981).","journal-title":"J. Clin. Pharmacol."},{"key":"BFsrep08126_CR44","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s002130050848","volume":"141","author":"M Haney","year":"1999","unstructured":"Haney, M., Ward, A. S., Comer, S. D., Foltin, R. W. & Fischman, M. W. Abstinence symptoms following oral THC administration to humans. Psychopharmacology (Berl.) 141, 385\u2013394 (1999).","journal-title":"Psychopharmacology (Berl.)"},{"key":"BFsrep08126_CR45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00204-013-1127-0","volume":"88","author":"B Mayer","year":"2014","unstructured":"Mayer, B. How much nicotine kills a human? Tracing back the generally accepted lethal dose to dubious self-experiments in the nineteenth century. Arch. Toxicol. 88, 5\u20137 (2014).","journal-title":"Arch. Toxicol."},{"key":"BFsrep08126_CR46","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/BF00422555","volume":"34","author":"IP Stolerman","year":"1974","unstructured":"Stolerman, I. P., Bunker, P. & Jarvik, M. E. Nicotine tolerance in rats; role of dose and dose interval. Psychopharmacologia (Berl.) 34, 317\u2013324 (1974).","journal-title":"Psychopharmacologia (Berl.)"},{"key":"BFsrep08126_CR47","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3109\/15563658909000358","volume":"27","author":"GE Minion","year":"1989","unstructured":"Minion, G. E., Slovis, C. M. & Boutiette, L. Severe alcohol intoxication: a study of 204 consecutive patients. J. Toxicol. Clin. Toxicol. 27, 375\u2013384 (1989).","journal-title":"J. Toxicol. Clin. Toxicol."},{"key":"BFsrep08126_CR48","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ejim.2007.06.033","volume":"19","author":"L Vonghia","year":"2008","unstructured":"Vonghia, L. et al. Acute alcohol intoxication. Eur. J. Intern. Med. 19, 561\u2013567 (2008).","journal-title":"Eur. J. Intern. Med."},{"key":"BFsrep08126_CR49","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1136\/bmj.309.6960.997","volume":"309","author":"M Farrell","year":"1994","unstructured":"Farrell, M. et al. Methadone maintenance treatment in opiate dependence: a review. BMJ 309, 997\u20131001 (1994).","journal-title":"BMJ"},{"key":"BFsrep08126_CR50","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11606-009-1225-0","volume":"25","author":"V Modesto-Lowe","year":"2010","unstructured":"Modesto-Lowe, V., Brooks, D. & Petry, N. Methadone deaths: risk factors in pain and addicted populations. J. Gen. Intern. Med. 25, 305\u2013309 (2010).","journal-title":"J. Gen. Intern. Med."},{"key":"BFsrep08126_CR51","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1385\/FSMP:1:2:097","volume":"1","author":"F Musshoff","year":"2005","unstructured":"Musshoff, F., Lachenmeier, K., Lachenmeier, D. W., Wollersen, H. & Madea, B. Dose-concentration relationships of methadone and EDDP in hair of patients on a methadone-maintenance program. Forensic Sci. Med. Pathol. 1, 97\u2013103 (2005).","journal-title":"Forensic Sci. Med. Pathol."},{"key":"BFsrep08126_CR52","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/0269881105048900","volume":"19","author":"AC Parrott","year":"2005","unstructured":"Parrott, A. C. Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy. J. Psychopharmacol. 19, 71\u201383 (2005).","journal-title":"J. Psychopharmacol."},{"key":"BFsrep08126_CR53","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s00213-003-1730-5","volume":"173","author":"F Schifano","year":"2004","unstructured":"Schifano, F. A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities. Psychopharmacology (Berl.) 173, 242\u2013248 (2004).","journal-title":"Psychopharmacology (Berl.)"},{"key":"BFsrep08126_CR54","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/bmj.289.6441.351","volume":"289","author":"PJ Cook","year":"1984","unstructured":"Cook, P. J., Flanagan, R. & James, I. M. Diazepam tolerance: effect of age, regular sedation and alcohol. Br. Med. J. (Clin. Res. Ed.) 289, 351\u2013353 (1984).","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"BFsrep08126_CR55","doi-asserted-by":"crossref","unstructured":"EFSA. Scientific opinion on the safety of hemp (Cannabis genus) for use as animal feed. EFSA J. 9, 2011 (2011).","DOI":"10.2903\/j.efsa.2011.2011"},{"key":"BFsrep08126_CR56","doi-asserted-by":"crossref","unstructured":"EFSA. Potential risks for public health due to the presence of nicotine in wild mushrooms. EFSA J. RN-286, 1\u201347 (2009).","DOI":"10.2903\/j.efsa.2009.286r"},{"key":"BFsrep08126_CR57","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s002130051067","volume":"145","author":"M Lindgren","year":"1999","unstructured":"Lindgren, M., Molander, L., Verbaan, C., Lunell, E. & Rosen, I. Electroencephalographic effects of intravenous nicotine\u2013a dose-response study. Psychopharmacol. (Berl.) 145, 342\u2013350 (1999).","journal-title":"Psychopharmacol. (Berl.)"},{"key":"BFsrep08126_CR58","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1111\/j.1360-0443.2011.03535.x","volume":"106","author":"I Rossow","year":"2011","unstructured":"Rossow, I. Can harm ratings be useful? Addiction 106, 1893\u20131894 (2011).","journal-title":"Addiction"},{"key":"BFsrep08126_CR59","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12916-014-0189-z","volume":"12","author":"J Rehm","year":"2014","unstructured":"Rehm, J., Lachenmeier, D. W. & Room, R. Why does society accept a higher risk for alcohol than for other voluntary or involuntary risks? BMC Med. 12, 189 (2014).","journal-title":"BMC Med."},{"key":"BFsrep08126_CR60","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1177\/002580248302300307","volume":"23","author":"LA King","year":"1983","unstructured":"King, L. A. & Moffat, A. C. A possible index of fatal drug toxicity in humans. Med. Sci. Law. 23, 193\u2013198 (1983).","journal-title":"Med. Sci. Law."},{"key":"BFsrep08126_CR61","unstructured":"Hall, W., Room, R. & Bondy, S. Comparing the Health and Psychological Risks of Alcohol, Cannabis, Nicotine and Opiate Use. The Health Effects of Cannabis [Kalant, H., Corrigal, W., Hall, W. & Smart, R. (eds.)] [477-506] (Addiction Research Foundation, Toronto, Canada, 1999)."},{"key":"BFsrep08126_CR62","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.drugpo.2011.04.004","volume":"22","author":"S Rolles","year":"2011","unstructured":"Rolles, S. & Measham, F. Questioning the method and utility of ranking drug harms in drug policy. Int. J. Drug Policy 22, 243\u2013246 (2011).","journal-title":"Int. J. Drug Policy"},{"key":"BFsrep08126_CR63","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/S0379-0738(03)00057-4","volume":"133","author":"F Musshoff","year":"2003","unstructured":"Musshoff, F., Lachenmeier, D. W. & Madea, B. Methadone substitution: medicolegal problems in Germany. Forensic Sci. Int. 133, 118\u2013124 (2003).","journal-title":"Forensic Sci. Int."},{"key":"BFsrep08126_CR64","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1111\/j.1360-0443.2011.03487.x","volume":"106","author":"B Fischer","year":"2011","unstructured":"Fischer, B. & Kendall, P. Nutt et al.'s harm scales for drugs\u2013room for improvement but better policy based on science with limitations than no science at all. Addiction 106, 1891\u20131892 (2011).","journal-title":"Addiction"},{"key":"BFsrep08126_CR65","unstructured":"Lachenmeier, D. W. & Rehm, J. Unrecorded Alcohol - No Worries Besides Ethanol: a Population-Based Probabilistic Risk Assessment. Alcohol policy in Europe: Evidence from AMPHORA. 2nd ed. [Anderson P., Braddick F., Reynolds J., & Gual A. (eds.)] [118\u2013130] (Alcohol Measures for Public Health Research Alliance (AMPHORA), Barcelona, Spain, 2013)."},{"key":"BFsrep08126_CR66","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/ijc.28336","volume":"134","author":"DW Lachenmeier","year":"2014","unstructured":"Lachenmeier, D. W., Godelmann, R., Witt, B., Riedel, K. & Rehm, J. Can resveratrol in wine protect against the carcinogenicity of ethanol? A probabilistic dose-response assessment. Int. J. Cancer 134, 144\u2013153 (2014).","journal-title":"Int. J. Cancer"},{"key":"BFsrep08126_CR67","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1089\/jcr.2013.0008","volume":"3","author":"DW Lachenmeier","year":"2013","unstructured":"Lachenmeier, D. W. et al. Caffeine intake from beverages in German children, adolescents and adults. J. Caffeine Res. 3, 47\u201353 (2013).","journal-title":"J. Caffeine Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep08126","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep08126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep08126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T19:46:31Z","timestamp":1672947991000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep08126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,30]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,7,15]]}},"alternative-id":["BFsrep08126"],"URL":"https:\/\/doi.org\/10.1038\/srep08126","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,30]]},"assertion":[{"value":"9 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8126"}}